Data management and support for accelerating Ng vaccine and antibody development
Official title: Core D - Data Management, Analysis and Product Development Support (CIIG)
Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-11394892 · Data updated 2026-11-12
A dedicated data and product development core helps speed up turning Neisseria gonorrhoeae vaccine and antibody research into actual human therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry M. Jackson Fdn for the Adv Mil/med NIH-funded |
| Lab location | 1 site (Bethesda, United States) |
| Project start | August 12, 2025 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $475,385 |
| NIH project number | 5U19AI189178-02 |
| Project ID | NIH-11394892 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals at risk for or affected by gonorrhea and those who may participate in related clinical trials or registries.
✕Less likely to help
Patients not directly involved in Ng vaccine or antibody development may not experience immediate benefits.
What this research studies
This grant centers on providing centralized platforms, tools, and expert support to CIIG Center projects, helping manage data, share results, and streamline study design and regulatory planning. It involves experienced staff in data platforms, statistics, and regulatory strategy to support translational work from lab findings to human use. The Core D team collaborates across disciplines to ensure efficient, compliant progression of Ng vaccines and therapeutic antibodies toward clinical testing. The goal is to accelerate translation while maintaining rigorous data sharing and analysis practices.
Why it matters
Potential benefit: If successful, patients could benefit from faster development of vaccines and antibody therapies against gonorrhea.
How similar studies have gone: Similar translational cores have accelerated vaccine and antibody development timelines in infectious disease research.
Where this research is happening
-
Henry M. Jackson Fdn for the Adv Mil/med
Bethesda, United States Active
Researchers
- Principal investigator: Sempowski, Gregory D — Henry M. Jackson Fdn for the Adv Mil/med
- Study coordinator: Sempowski, Gregory D
Related research
Other NIH-funded projects on the same topics.
-
Cooperation partners of SETBP1 in AML development
This grant explores how SETBP1 and AF9 (MLLT3) work together to drive acute myeloid leukemia and whether targeting related epigenetic regulators could help treat aggressive CK-AML.
-
U.S. Military HIV Research Program Clinical Trials Unit expansion
A nationwide network of clinical trial sites is being expanded to test HIV prevention and treatment approaches through DAIDS-supported trials.
-
Novel protein biomarkers of chronic pain in adults using a pain registry biobank
A study in adults with chronic pain will look for new protein biomarkers in blood samples to understand better why pain persists and how to improve treatment.
-
Tailored antibody cures for HIV using AI and vaccines
A study to design personalized antibody-based strategies to achieve HIV remission, using lab experiments and computer models to tailor vaccines or antibody treatments to individuals or small groups.
-
Understanding how antibody protection works using 3D protein structures
Researchers will build a 3D-based method to see which viral features relate to prevention by antibodies, using data from people in HIV vaccine and monoclonal antibody trials.
-
Military HIV Clinical Network
This program runs HIV and TB prevention and treatment clinical studies for adults in military-associated and high-HIV-burden communities.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.